World Journal of Surgery

, Volume 29, Issue 6, pp 759–765

Protein C as an Early Marker of Severe Septic Complications in Diffuse Secondary Peritonitis

  • Aleksandar Karamarkovic
  • Dejan Radenkovic
  • Natasa Milic
  • Vesna Bumbasirevic
  • Branislav Stefanovic
Article

Abstract

To evaluate the predictive value of protein C as a marker of severity in patients with diffuse peritonitis and abdominal sepsis, protein C levels were repeatedly determined and compared with serum levels of antithrombin III, plasminogen, α2-antiplasmin, Plasminogen activator inhibitor, D-dimer, C1-inhibitor, high molecular weight kininogen, and the C5a, C5b-9 fragments of the complement system. We carried out a prospective study from 44 patients with severe peritonitis confirmed by laparotomy and 15 patients undergoing elective ventral hernia repair who acted as controls. Analyzed biochemical parameters were determined before operations and on days 1, 2, 3, 5, 7, 10, and 14 after operations. For the study group, preoperative average protein C level was significantly lower in the patients who developed septic shock in the late course of the disease, with lethal outcome, than in the patients with severe peritonitis and sepsis who survived (p = 0.0001). In non-survivors, protein C activity remained decreased below 70%, whereas the course of survivors was characterized by increased values that were significantly higher (p < 0.03) at every time point than in those patients who died. Protein C was of excellent predictive value and achieved a sensitivity of 80% and a specificity of 87.5% in discriminating survivors from non-survivors within the first 48 hours of the study (AUC-0.917; p < 0.001), with a “cut-off” level of 66.0%. As for the control group, throughout the study period, protein C activity was permanently maintained within the range of normal, with significant differences with reference to the study group (p < 0.01). These results suggest that protein C represents a sensitive and early marker for the prediction of severe septic complications during diffuse peritonitis, and of outcome.

Keywords

protein C peritonitis septic abdomen abdominal sepsis 

References

  1. 1.
    Baue, AE, Durham, R, Faist, E. 1998Systemic inflammatory response syndrome (SIRS), multiple organ dysfynction syndrome (MODS), multiple organ failure (MOF): are we winning battle?Shock107989PubMedGoogle Scholar
  2. 2.
    Wittmann, DH, Aprahamian, C, Bergstein, JM,  et al. 2000STAR and STIR effectively treat abdominal compartment syndrome and reduce mortality of traumatic and infectious abdominal catastrophesJ. Int. Care Med.15201220CrossRefGoogle Scholar
  3. 3.
    Farthmann, EH, Schoffel, U. 1990Principles and limitations of operative management of intaabdominal infectionsWorld J. Surg.14210217CrossRefPubMedGoogle Scholar
  4. 4.
    Garcia-Sabrido, JM, Talado, JM, Christou, NV. 1988Tretment of severe intaabdominal sepsis and/or necrotic foci by an open abdomen approach: Zipper and zipper-mesh techniquesArch. Surg.123152156PubMedGoogle Scholar
  5. 5.
    Berger, D. 1996The role of endotoxin in peritonitisDig. Surg.13384389Google Scholar
  6. 6.
    Carvalho, AC, Freeman, NJ. 1994How coagulation defects alter outcome in sepsisJ. Crit. Illness95175Google Scholar
  7. 7.
    Boldt, J 2001

    Changes of the hemostatic network in the critically ill

    Vincent, JL eds. Yearbook of Intensive Care and Emergency MedicineSpringer-VerlagBerlin287295
    Google Scholar
  8. 8.
    Schein, M, Wittman, DH, Holzheimer, R,  et al. 1996Hypothesis: compartmentalizacion of cytokines in intra-abdominal infectionSurgery11694700Google Scholar
  9. 9.
    Bernard, GR, Hartmann, DL, Helterbrand, JD,  et al. 1999Recombinant human activated protein C (rhAPC) produces a trend toward improvement in morbidity and 28-day survival in patients with severe sepsisCrit. Care Med.27S33S35CrossRefGoogle Scholar
  10. 10.
    Bernard, GR, Macias, WL, Joyce, DE,  et al. 2003Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsisCrit. Care7155163CrossRefPubMedGoogle Scholar
  11. 11.
    Yan, SB, Dhainaut, JF. 2001Activated protein C versus protein C in severe sepsisCrit. Care Med.29S69S74CrossRefPubMedGoogle Scholar
  12. 12.
    Dhainaut, JF, Yan, SB, Cariou, A,  et al. 2002Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsisCrit. Care Med.30S318S323CrossRefPubMedGoogle Scholar
  13. 13.
    Bernard, GR, Vincent, JL, Laterre, PF. 2001Efficiacy and safety of recombinant human activated protein C for severe sepsisN. Engl. J. Med.344699709CrossRefPubMedGoogle Scholar
  14. 14.
    Mesters, MR, Helterbrand, J, Utterback, B,  et al. 2000Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complicationsCrit. Care Med.2822092216CrossRefPubMedGoogle Scholar
  15. 15.
    Marlar, RA, Endres, BJ, Miler, C. 1985Serial studies of protein C and its plasma inhibitor in patients with DICBlood665963PubMedGoogle Scholar
  16. 16.
    Jonge, E, Levi, M, Poll, T 2001

    Natural anticoagulants in disseminated intravascular coagulation and sepsis

    Vincent, JL eds. Yearbook of Intensive Care and Emergency MedicineSpringer-VerlagBerlin348352
    Google Scholar
  17. 17.
    Hartmann, DL, Bernard, GR. 1998Protein C activity by baseline predicts the development of shock and 28 day mortality in patients with severe sepsisIntens. Care Med.24S138S148CrossRefGoogle Scholar
  18. 18.
    Fourrier, F, Chopin, C, Goudemand, J. 1992Septic shock, multiple organ failure and disseminated intravascular coagulation. Compared patterns of AT III, protein C and protein S deficiencesChest101816823PubMedGoogle Scholar
  19. 19.
    Hesselvik, JF, Malm, J, Dahlback, BF. 1991Protein C, protein S and C4b binding protein in severe infection and septic shockThromb. Haemost.65126129PubMedGoogle Scholar
  20. 20.
    Vincent, JL, Angus, DC, Artigas, A,  et al. 2003Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWES trialCrit. Care Med.31834840CrossRefPubMedGoogle Scholar
  21. 21.
    Aasen, AO. 1985The proenzyme functional inhibition index. A new parameter for evaluation of the severely injured and septic patientsActa Chir. Scand.522211233Google Scholar
  22. 22.
    Aasen, AO 1990

    The role of proteolytic enzyme systems with particular emphasis on the plasma kalikrein-kinin system during septicemia and septic shock

    Vincent, JLThijs, LG eds. Septic ShockSpringer-VerlagBerlin16128
    Google Scholar
  23. 23.
    Meijers, JC, Bouma, BN. 1999New concepts in activation of the clotting cascade in sepsisSepsis38791CrossRefGoogle Scholar
  24. 24.
    American College of Chest Physicians/Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 1992; 20: 864–874Google Scholar
  25. 25.
    Anaya, DA, Nathens, AB. 2003Risk factors for severe sepsis in secondary peritonitisSurg. Infect.4355362CrossRefGoogle Scholar
  26. 26.
    Rau, B, Kruger, CM, Schilling, MK. 2004Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsisLangenbecks Arch. Surg.389134144CrossRefPubMedGoogle Scholar
  27. 27.
    Teichman, W, Herbig, B. 1996Scheduled reoperations for diffuse peritonitisDig. Surg.13396399Google Scholar
  28. 28.
    Wittman, DH, Schein, M, Condon, RE. 1996Management of secondary peritonitisAnn. Surg.2241018CrossRefPubMedGoogle Scholar
  29. 29.
    Wittmann, DH. 1998Operative and nonoperative therapy of intra-abdominal infectionsInfection26335351PubMedGoogle Scholar
  30. 30.
    Levi, M, Poll, T, ten Gate, H,  et al. 1997The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxemiaEur. J. Clin. Ivest.2739CrossRefGoogle Scholar
  31. 31.
    Macias, WL, Nelson,  2004Severe protein C deficiency predicts early death in severe sepsisCrit. Care Med.32S223S228CrossRefPubMedGoogle Scholar
  32. 32.
    Hazelzet, JA, Voort, E, Lindermans, J,  et al. 1994Relation between cytokines and routine laboratory data in children with septic shock and purpuraIntens. Care Med.20371374CrossRefGoogle Scholar
  33. 33.
    Fijnvandraat, K, Derkx, B, Peters, M,  et al. 1995Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortalityThromb. Haemost.731520PubMedGoogle Scholar
  34. 34.
    Roman, J, Velasco, F, Fernandez, F,  et al. 1992Protein C, protein S and C4b binding protein in neonatal severe infection and septic shockJ. Perinat. Med.20111116PubMedGoogle Scholar
  35. 35.
    Leclerc, F, Hazelzet, J, Jude, B,  et al. 1992Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 casesIntens. Care Med.18202205CrossRefGoogle Scholar
  36. 36.
    Powars, D, Larsen, R, Johnson, J,  et al. 1993Epidemic meningococcemia and purpura fulminans with induced protein C deficiencyClin. Infect. Dis.17254261PubMedGoogle Scholar
  37. 37.
    Lorente, JA, Garcia-Frade, LJ, Landin, L,  et al. 1993Time course of hemostatic abnormalities in sepsis and its relation to outcomeChest10315361542PubMedGoogle Scholar
  38. 38.
    Fisher, CJ,Jr, Yan, SB. 2000Protein C levels as a prognostic indicator of outcome in sepsis and related diseasesCrit. Care Med.28S49S56CrossRefPubMedGoogle Scholar
  39. 39.
    Pastores, SM, Papadopulos, E, Brink, M,  et al. 2002Septic shock and multiple organ failure after hematopoetic stem cell transplantation: treatment with recombinant human activated protein CBone Marrow Transplant.30131134CrossRefPubMedGoogle Scholar
  40. 40.
    Macias, WL, Derchak, PA. 2003Coagulopathy may occur before the clinical diagnosis of organ dysfunctionCrit. Care Med.31S100S110Google Scholar

Copyright information

© Société Internationale de Chirurgie 2005

Authors and Affiliations

  • Aleksandar Karamarkovic
    • 1
  • Dejan Radenkovic
    • 1
  • Natasa Milic
    • 2
  • Vesna Bumbasirevic
    • 3
  • Branislav Stefanovic
    • 1
  1. 1.Center for Emergency SurgeryClinical Center of Serbia, School of Medicine, University of BelgradeBelgrade
  2. 2.Institute of Medical StatisticSchool of Medicine, University of BelgradeBelgrade
  3. 3.Institute of AnaesthesiologyClinical Center of Serbia, School of Medicine, University of BelgradeBelgrade

Personalised recommendations